Neurotech International Future Growth
Future criteria checks 1/6
Neurotech International's earnings are forecast to decline at 26.1% per annum while its annual revenue is expected to grow at 16.9% per year. EPS is expected to decline by 21% per annum. Return on equity is forecast to be -79% in 3 years.
Key information
-26.1%
Earnings growth rate
-21.0%
EPS growth rate
Medical Equipment earnings growth | 16.0% |
Revenue growth rate | 16.9% |
Future return on equity | -79.0% |
Analyst coverage | Low |
Last updated | 12 Dec 2024 |
Recent future growth updates
No updates
Recent updates
Why Neurotech International Limited (ASX:NTI) Could Be Worth Watching
Nov 19Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 19Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
Jan 28We Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefully
Oct 14Here's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Jul 01Is Neurotech International (ASX:NTI) In A Good Position To Invest In Growth?
Jan 21Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Oct 06Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
May 18We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate
Dec 21Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 04Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares
Dec 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 4 | -9 | -9 | -9 | 1 |
6/30/2025 | 3 | -10 | -10 | -10 | 1 |
6/30/2024 | 3 | -5 | -5 | -5 | N/A |
3/31/2024 | 3 | -5 | -4 | -4 | N/A |
12/31/2023 | 3 | -5 | -4 | -4 | N/A |
9/30/2023 | 2 | -6 | -5 | -5 | N/A |
6/30/2023 | 1 | -8 | -6 | -6 | N/A |
3/31/2023 | 1 | -6 | -5 | -5 | N/A |
12/31/2022 | 2 | -5 | -4 | -4 | N/A |
9/30/2022 | 1 | -4 | -4 | -4 | N/A |
6/30/2022 | 1 | -3 | -3 | -3 | N/A |
3/31/2022 | 0 | -4 | -3 | -3 | N/A |
12/31/2021 | 0 | -6 | -3 | -3 | N/A |
9/30/2021 | 0 | -7 | -3 | -3 | N/A |
6/30/2021 | 0 | -7 | -2 | -2 | N/A |
3/31/2021 | 0 | -6 | -2 | -2 | N/A |
12/31/2020 | 0 | -5 | -1 | -1 | N/A |
9/30/2020 | 0 | -3 | -1 | -1 | N/A |
6/30/2020 | 0 | -2 | -1 | -1 | N/A |
3/31/2020 | 0 | -3 | -1 | -1 | N/A |
12/31/2019 | 0 | -4 | -1 | -1 | N/A |
9/30/2019 | 0 | -4 | -2 | -2 | N/A |
6/30/2019 | 0 | -5 | -3 | -3 | N/A |
3/31/2019 | 0 | -4 | -3 | -3 | N/A |
12/31/2018 | 0 | -4 | -4 | -3 | N/A |
9/30/2018 | 0 | -4 | -4 | -3 | N/A |
6/30/2018 | 0 | -4 | -4 | -3 | N/A |
3/31/2018 | 0 | -4 | N/A | -3 | N/A |
12/31/2017 | 0 | -4 | N/A | -3 | N/A |
9/30/2017 | 0 | -4 | N/A | -3 | N/A |
6/30/2017 | 0 | -4 | N/A | -3 | N/A |
12/31/2016 | 0 | -4 | N/A | -3 | N/A |
9/30/2016 | 0 | -4 | N/A | -2 | N/A |
6/30/2016 | 0 | -3 | N/A | -2 | N/A |
12/31/2015 | 0 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NTI's revenue (16.9% per year) is forecast to grow faster than the Australian market (5.9% per year).
High Growth Revenue: NTI's revenue (16.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NTI is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/04 07:27 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Neurotech International Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrew Goodsall | MST Financial Services Pty Limited |